cytic leukemia (PLL) of the B type, and one patient with CLL of the T type. In a second case of B-type CLL, the leukemic cells were prepared from the patient's spleen (1,500 g), which was heavily infiltrated by leukemic cells, by pressing the splenic tissue through a nylon mesh, followed by Urografin-(E. R. Squibb & Sons, New York) Ficoll (Pharmacia Fine Chemicals, Inc., Uppsala, Sweden) gradient centrifugation of the cells (21) . The lymphocytes from the two cases of B-type CLL expressed small amounts of surface immunoglobulin (SIg), bore receptors for erythrocytes coated with IgM antibodies and C3d (EAC3d) and mouse eryth, rocytes (E), but lacked receptors for sheep E and E coated with IgM antibodies and C3b (EAC3b). The PLL cells showed a thick layer of IgM/K and Clq on their surface and receptors for EAC3b and EAC3d, but lacked receptors for mouse E and sheep E. The cells from all three B-type leukemias bound IgG aggregates and ox E coated with anti-E antibodies of the IgG type (IgGEoxA) in a percentage ranging from 40 to 95%. Sheep E coated with anti-E antibodies of the IgM type (IgM-EA) were not bound by the leukemic B cells. The T-type CLL cells were SIg negative and Ia-like-antigen negative and did not bind aggregated IgG-fluorescein isothiocyanate (FITC) or IgG-EoxA, but formed rosettes with sheep E at 4°C.
lgG Aggregates. Human IgG was prepared from pooled human sera by fractionation with ammonium-sulfate precipitation followed by chromatography on DEAE-cellulose equilibrated with 0.0175 M phosphate buffer, pH 7.0. The IgG (20 mg/ml) was aggregated by heating at 63°C for 28 min (22) . Soluble IgG aggregates with a mol wt between 2.5 × 107 and 3 × 107 were obtained by chromatography on a Sepharose 2B column (Pharmacia Fine Chemicals, Inc., 100 × 1.5 cm) calibrated with IgG, IgM, and dextran blue; and equilibrated with phosphate-buffered saline (PBS).
F(ab')~ Aggregates. F(ab'
2 fragments were prepared by cleaving IgG with pepsin and purification on a Sephadex G-150 column (Pharmacia Fine Chemicals, Inc., 100 X 2.5 cm) (23) . Soluble F(ab')~ aggregates were obtained by the same procedure as that described for IgG aggregates.
Soluble Peroxidase-Anti-Peroxidase-lgG (PAP-IgG ) and -F (ab' ) e (PAP-F[ab " ]~ ) Complexes.
Soluble PAP-IgG complexes consisting of three molecules of horseradish peroxidase and two molecules of rabbit anti-peroxidase IgG-type antibodies were obtained from Dakopatts A/S, Copenhagen, Denmark. Fc fragments were cleaved from PAP-IgG with pepsin. The resulting PAP-F(ab')2 complexes were purified on a calibrated Uhrogel AcA 22 column (LKB Produkter, Bromma, Sweden, 100 × 2.5 cm).
Preparation of Uncoated E Membrane Sheets and those Coated with IgG. 1 × 109 sheep E (E~) were
incubated at 37°C for 30 min in 3 ml of the IgG fraction of a rabbit anti-Es serum with an agglutination titer of 1:32,000. The strongly agglutinated E~ were washed twice in PBS. The ag~glutinated E, and 1 X I0 ~ untreated E~ were homogenized by nitrogen cavitation (1,400 lb/ in, 20 min). The resulting membrane sheets were then washed several times and homogenized with a Potter-Elvehjem homogenizer until all contaminating hemoglobin was removed.
Coupling of Proteins to Sepharose 4B. Proteins were coupled to cyanogen bromide (CNBr)-activated Sepharose 4B as described by Cuatrecasas et al. (24) .
Radioiodination. Proteins and purified cell membranes were labeled with 125I (Amersham
Buchler Radiochemicals, Braunschweig, West Germany) using chloramine T (25) . The cell membranes of intact cells were enzymatically iodinated with lactoperoxidase (1 mCi 125I/1 × 108 cells) (26) . Unbound x~5I was removed by passage over a Sephadex G-25 column or by exhaustive washing.
antibodies; EAC3b, erythrocytes coated with antibodies and C3b; EAC3d, erythrocytes coated with antibodies and C3d; EDTA-ME, a mixture of Na-EDTA and 2-mercaptoethanol; FITC, fluorescein isothlocyanate; GAR-R, rhodamine-labeled goat anti-rabbit IgG y-globulin; IgG-EA, erythrocytes coated with anti-erythrocyte antibodies of the IgG type; IgG-EhuA, Rh-positive human type-O erythrocytes coated with human anti-erythrocyte antibodies of the IgG type; IgO-EoxA, ox erythrocytes coated with antierythrocyte antibodies of the tgG type; IgG-E~A, sheep erytbrocytes coated with rabbit anti-erythrocyte antibodies of the IgG type; IgM-EA, sheep erythroeytes coated with anti-erythrocyte antibodies of the IgM type; ME, 2-mercaptoethanol; NP-40, Nonidet P-40; PAP-F(ab')2, soluble complex of horseradish peroxidase and F(ab')2 fragments; PAP-IgG, soluble complex of horseradish peroxidase and anti-peroxidase antibodies of IgG type; PBS, phosphate-buffered saline; pI, isoelectric point; PLL, prolymphocytic leukemia; SDS, sodium dodecyl sulfate; SIg, surface immunoglobulin.
Isolation of Cell Membranes. Cells were homogenized by nitrogen cavitation (800 lb/in 2, 20 min), and membranes were pelleted at 105,000 g for 60 rain after differential centrifugation at 600 g and 20,000 g for 30 min (27) .
Preparation of CeU-Membrane Lysate. Purified membranes were incubated in 80 mM Na-EDTA/50 mM 2-mereaptoethanol (ME) (EDTA-ME) in 20 mM Tris-HCl, pH 7.3, or 0.1% Nonidet P-40 (NP-40, Shell Chemical Co., New York) in 20 mM Tris-HCl, pH 7.3, or 0.5% sodium deoxycholate (DOC) in 20 mM Tris-HCl, pH 7.3, at 4°C for 20 min. Insoluble material was removed by centrifugation at 105,000 g for 60 rain. The supernate was used immediately.
Isolation of Fcy-binding Protein. Iodinated membrane lysates obtained from 2 × l0 s cells were routinely incubated with IgG aggregates or, in some experiments, with soluble PAP-IgG complexes at 37°C for 30 minutes and then coprecipitated with a sheep anti-human IgG serum or a sheep anti-rabbit IgG serum, respectively. The coprecipitates were exhaustively washed. In some experiments, IgG aggregates or F(ab')2 aggregates were incubated with 12~I-labeled membrane lysates and separated from unbound membrane proteins by chromatography on a calibrated Sepharose 2B column. In other experiments, Fcy-binding proteins were isolated by incubating iodinated membrane lysates with IgG-coated E8 membrane sheets at 37°C for 30 minutes, followed by exhaustive washing in 0.1 M Tris-HCl, pH 7.2. The material obtained by all of these methods was boiled in sodium dodecyl sulfate (SDS) sample buffer for 2 rain. In a third set of experiments, iodinated membrane lysates were incubated at 37°C for 30 rain with 1 mg of either aggregated IgG, aggregated F(ab')2, PAP-IgG, or PAP-F(ab')2 coupled to 1 ml Sepharose 4B. After exhaustive washing in PBS, the pelleted Sepharose 4B was boiled in SDS sample buffer for 2 min. The absorbed material was separated from the Sepharose 4B matrix by passage through a Whatman GF/A filter (Whatman Chemicals, Div. of W. & R. Balston, Maidstone, Kent, England), followed by 10-fold concentration with Ultrathimbles (UH 100/ 25; Schleicher & Schiill GmbH, Dassel, West Germany).
Isolation of Fcy-binding protein by means of column affinity chromatography was performed as follows. Aggregated IgG was coupled to CNBr-activated Sepharose 4B (24) . After equilibration with PBS, 12SI-labeled membrane lysate from 1 × 109 cells was applied to the column and incubated at 22°C for 30 min. The column was washed in PBS until radioactivity decreased to the baseline; retained proteins were eluted with 0.1 M glycine-HCl buffer, pH 2.8. Eluates were neutralized and incubated with 0.1 mg aggregated IgG at 37°C for 30 min. The incubated, aggregated IgG was isolated by copreeipitation as described above.
SDS-Polyac,ylamide Gel Electrophoresis. SDS electrophoresis was performed on cylindrical gels according to the method described by Laemmli (28) . The stacking and separating gel combinations used were either 3.5% and 7.5%, or 3.5% and 10% polyacrylamide concentration. Samples were pretreated by heating for 2 min in 2% (wt/vol) SDS dissolved in gel-loading buffer, either with or without 100 mM ME. By adding 1 M iodoacetamide, the reduced samples were alkylated to a final concentration of 100 raM. Unreduced human IgG, reduced bovine serum albumin, y-chains, and reduced myeloma light (A) chains were routinely used as internal markers. After electrophoresis, the gels were sliced into 1-mm segments and radioactivity was determined in a y-counter (BF 5300, Berthold GmbH, Wildbad, West Germany).
Isoelectric Focusing. Isoelectric focusing was performed in cylindrical 5% polyacrylamide gels in the presence of 6 M urea. The gels contained 5% Ampholine (LKB Produkter) in the pH ranges 3.5-10 (four parts) and 4-6 (one part). The pH gradient was established at 150 V for 2 h. Coprecipitates dissolved in 8 M urea were applied to gels and focused for 16 h at 150 V and 0.4-0.5 mA per gel. After focusing, the gels were cut into l-ram segments and radioactivity was determined. For determination of the final pH gradient, two parallel gels were cut into 20 segments, and the pH was measured in the distilled water eluates of each segment with a conventional pH meter.
Determination of NH~Terminal Amino Acid. Membranes from 1 × 101° lymphocytes were solubilized with EDTA-ME, and Fcy-binding proteins were isolated from membrane lysates by incubation with IgG aggregates and coprecipitation with sheep anti-human IgG serum. After exhaustive washing in 0.15 M Tris-HCl, pH 7.5, the complexes were dissociated by incubation in 0.1 M citrate buffer, pH 2.8, for 20 rain at room temperature, followed by chromatography on an Uhrogel AcA-34 column. Fractions corresponding to a tool wt of 28,000 were collected, dialyzed against water, and lyophilized. Determination of the NH2-terminal amino acid was performed by reaction of dansyl chloride with the protein, followed by hydrolysis and thin-layer chromatography of amino acids (29) . Dansylated amino acids were used as references (Serva Feinbioehemica, Heidelberg, West Germany).
Complexes of E and Anti-E Antibodies of the IgG Type (IgG-EA). Various IgG-EA complexes were prepared. IgG-EoxA was prepared by incubating ox E (Eo~) in a hyperimmune rabbit serum, which had a low Eox-agglutination titer and a high hemolysis titer, at 37°C for 30 min. Complexes of Rh-positive human type-O E (F-,hu) and human anti-E antibodies of the IgG type (IgG-EhuA) were prepared by incubating Ehu in a human serum containing a high titer (indirect-Coombs-test positive to a final dilution of 1:2,000) of nonagglutinating anti-D antibodies. Complexes of Es and rabbit anti-E antibodies of the IgG type (IgG-EsA) were prepared by incubating E~ in the IgG fraction of a rabbit anti-E~ serum at a barely nonagglutinating titer. The highest percentage of rosettes and the most-stable rosettes were obtained with IgG-EozA. IgG-EhuA yielded 20-60% and IgG-E~A, 40-95% lower percentages of rosetting cells. Thus, IgG-Eo~A was routinely used in our experiments.
IgM-EA. IgM-EA was prepared by incubating E~ in the IgM fraction of an anti-Es serum at a barely nonagglutinating titer. The IgM fraction was obtained by fractionation of the antiserum by means of ammonium-sulfate precipitation followed by passage through an Ultrogel AcA-34 column. The IgM nature of the sensitizing antibodies was ascertained by titration of the IgM-EA against monovalent anti-rabbit IgM and anti-rabbit IgG sera (obtained from Nordic Immunological Laboratories, Tilburg, The Netherlands).
Rosette Formation. 2 × 106 leukemic cells were incubated with 8 × 107 of IgG-EA complexes or IgM-EA in small plastic conical tubes (Eppendorf GmbH, Hamburg, West Germany) at 37°C for 5 rain, followed by centrifugation at 200 g for 5 min and a second incubation at 37°C for 20 min. Afterwards, the cells were gently resuspended and kept on ice until counting.
Rosette-inhibition Assay. For detection of soluble Fcy-binding protein, IgG-Eo~A and/or IgGEhuA were preincubated in EDTA-ME membrane lysate. The rosette assay was then performed.
For detection of agents blocking membrane receptors, the rosette tests were performed either in the presence of the agents (monomeric IgG, IgG aggregates, PAP-IgG, 19S IgM, carrageenin, or polyinosinic acid; the latter two obtained from Sigma Chemical Co., St. Louis, Mo.) or after preincubation of the leukemic cells with the agents (anti-C 1 q serum or anti-Fcy-receptor sera), followed by two washings. The inhibition of rosette formation was calculated with the method of Dierich and Reisfeld (30) .
Binding of PAP-IgG. 5 × 108 leukemic cells were incubated at 37°C for 30 rain with 50/~1 PAP-IgG at various dilutions. After three washings, centrifuge slides were prepared and fixed in a 1% PBS-buffered glutaraldehyde solution for 1 min, followed by two washings in 0.05 M Tris-HCl buffer, pH 7.6. The slides were then incubated at 22°C for I0 min in Tris-HCl buffer containing 3',3'-diaminobenzidine tetrahydrochloride (Sigma Chemic, Munich, West Germany) (0.5 mg/mi, pH 7.6) and 0.001% HzO2. After several washings, the slides were counterstained with hemalum and mounted with Eukitt (Odelie Kindler, Freiburg, West Germany).
Antisera. Anti-Fcy-receptor sera were prepared as follows. IgG-EoxA was incubated in EDTA-ME membrane lysate from the case of PLL and washed twice. The coating of the IgGEoxA with Fcy-binding protein was monitored by reduction of rosette formation. Three rabbits were immunized i.v. weekly with 5 X l0 s of the incubated IgG-EoxA, which showed rosette formation reduced by at least 60%. Blood was obtained weekly, starting 1 mon after the first immunization. The antisera were exhaustively absorbed with Eoz, Ehu, EB, and glutaraldehydeinsolubilized serum protein, and partly absorbed with human brain homogenate and C1 (Cordis Laboratories Inc., Miami, Fla.). The absorbed and diluted (1:30) anti-Fcy-receptor sera showed IgG-EA-rosette inhibition of 60-80% when compared with 1:30-diluted normal rabbit serum, whereas they did not suppress the binding of EAC3b and neuraminidase-treated E, to appropriate cells. The anti-Fcy-receptor sera stained Fcy-receptor-positive leukemic cells, but not cells from T-type CLL, thymocytes, T cells of peripheral blood, erythrocytes, or Fcyreceptor-negative EU-I-eell line cells (kindly donated by Dr. U. Schneider, Erlangen, West Germany) in indirect immunofluorescence.
Sheep anti-human IgG serum and sheep anti-rabbit IgG serum were produced by immunizing sheep with purified human IgG or rabbit IgG by means of the procedure of Hijmans et al. (31) . The anti-human IgG serum was absorbed with Eh~, human brain homogenate, PLL cells, and glutaraldehyde-insolubilized purified IgM. This antiserum agglutinated only E coated with human IgG and not E coated with other proteins. The anti-rabbit IgG serum was absorbed with glutaraldehyde-insolubilized human serum polymer, Ehu, and PLL cells.
Anti-Eo~ sera containing a large amount of IgG antibodies were obtained by immunizing rabbits i.v. weekly with 1 × 101° Eox for 3 mon. Only the anti-Eox sera showing a low agglutination titer (1:4-1:8) and a high hemolysis titer (1:2,000, demonstrated by adding 1:64-diluted guinea pig serum) were used.
Anti-E8 sera with a high content of IgM antibodies were prepared by immunizing rabbits i.v. with 1 × 10 a° E8 three times per wk for 3 wk. The first blood sample was taken and tested on the 14th d after the first immunization. The sera with the highest ME-(final concentration of 0.1 M) sensitive agglutination titers were pooled.
Anti-E~ sera with a high content of IgG antibodies were obtained by immunizing rabbits weekly with 1 × 10 I° E~ for 3 mon. The |gG fraction was isolated as described for human IgG.
The nonagglutinating human anti-D serum was a generous gift from Dr. Sachs, Blutspendezentrale, University of Kiel, Kiel, West Germany. Anti-Clq serum was obtained from Behring Werke AG, Marburg/Lahn, West Germany.
Immunofluorescent Staining. IgG aggregates were conjugated with FITC according to the method of Clark and Shepard (32) . Goat anti-rabbit IgG-rhodamine isothiocyanate conjugate (Nordic Immunological Laboratories) was additionally absorbed with human tonsil cells before use in the indirect procedure. The staining procedure described by Vossen (33) was used. Control stainings performed with normal rabbit serum absorbed with Ehu, tonsil cells, brain and serum polymer, and an anti-arfetoprotein serum (Dakopatts A/S) were completely negative at dilutions higher than l:15. The anti-Fcy-receptor sera were usually used at a dilution of 1:20 for indirect immunofluorescence.
Results

Properties of the Cell-bound Fcy Receptor.
A large proportion (40%, 70%, and 95%, respectively) of cells from the three B-type leukemias bound FITC-labeled IgG aggregates, IgG-EoxA, and PAP-IgG; a smaller proportion bound IgG-EhuA and IgG-E~A, but none bound IgM-EA. Cells from the case of T-type CLL and Ehu, both of which were used as control cells, neither bound detectable amounts of IgG aggregates labeled with FITC, nor of PAP-IgG, nor formed rosettes with IgG-EoxA. As shown in Fig. 1 , the binding of IgG-Eo~A to the leukemic B cells decreased with the addition of increasing amounts of IgG aggregates and monomerie IgG. A 200-fold molar excess of monomeric IgG was needed to achieve an inhibitory effect on IgG-Eo~A-rosette formation similar to that of IgG aggregates. IgG-Eo~A-rosette inhibition by monomeric IgG did not exceed 80%, even with 1.5 mg monomeric IgG. Nearly complete inhibition of IgG-EoxA-rosette formation could be obtained only with IgG aggregates. A similarly marked rosette inhibition was observed with PAP-IgG. IgG-EoxA-rosette formation was not affected by the presence of purified IgM, carrageenin, or polyinosinic acid, or by preincubation of the leukemic cells with anti-Clq serum. Preincubation of the leukemic cells with diluted (1:30) anti-Fcy-receptor sera, however, decreased IgGEo~A-rosette formation by >70% when compared with normal rabbit serum, whereas it did not affect rosette formation with EAC3b.
Solubilization of Fcy Region-spec~'c Protein and Properties of the Solubilized Molecules.
First, we solubilized membranes of the leukemic B cells, obtained by rupturing the cells by means of the nitrogen cavitation method and differential centrifugation, with NP-40. After iodination, the membrane lysates were incubated with IgG aggregates and then coprecipitated with an anti-IgG serum. SDS-polyacrylamide gel electrophoresis of the coprecipitates revealed six major peaks with mol wt ranging from 15,000 to 115,000 (Fig. 2, solid line) . A basically similar SDS pattern was obtained with F(ab')2 aggregates (Fig. 2, dotted line ). An Fc7 region-specific protein could not be coprecipitated from DOC-solubilized membranes either. These disappointing results encouraged us to try nondetergent agents. Good results were obtained with a mixture of EDTA and ME. EDTA-ME membrane lysates dialyzed against PBS strongly inhibited the binding of IgG-Eo~A to leukemic B cells. The inhibition was dosedependent (Fig. 3) . Even highly concentrated EDTA-ME lysates, however, did not agglutinate IgG-EoxA. Absorption of the membrane lysates with IgG-EoxA, but not with uncoated Eox, removed the capacity of the membrane lysates to inhibit the binding of IgG-EoxA to leukemic B cells.
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Isolation of the IgG-binding material from EDTA-ME lysates of the leukemic to Sepharose 4B, and (e) affinity chromatography on aggregated IgG-Sepharose 4B columns. SDS preparations from all types of material revealed identical patterns in SDS-polyacrylamide gel electrophoresis, viz.: one small-based peak with an apparent mol wt of 28,000 (Figs. 4 and 5, solid lines). The highest peak was obtained with PAP-IgG (not shown). An identical protein peak was isolated from membranes that had been prepared from surface-iodinated viable leukemic B cells, which confirmed that the isolated protein was a cell-surface protein. Reduction and alkylation of the Fc2,-binding protein did not affect its relative mobility; its NH2-terminal amino acid was determined to be glycine. Thin-layer chromatography of the dansylated receptor protein not subjected to acid hydrolysis did not show a fluorescent spot representing noncovalently bound glycine. Material with binding affinity to aggregated or c0mplexed IgG could not be isolated from lysates of iodinated and isolated membranes of cells from a human leukemia of the T type or Ehu (Fig. 6, dotted and solid lines) . Furthermore, no electrophoretic peak at all could be obtained with EDTA-ME lysates of the membranes of the B-type leukemia cells (Figs. 4 and 5 , dotted'lines) when F(ab')2 aggregates were used instead of IgG aggregates, when PAP-F(ab')2 complexes were used instead of intact PAP-IgG molecules, or when uncoated E membrane sheets were used instead of IgG-coated E membrane sheets.
Attempts to elute Fcy-binding protein, without denaturation, from aggregated IgGSepharose 4B columns with 0.1 M glycine-HC1, pH 2.8, yielded only small amounts of iodinated material when compared with eluates obtained with SDS. Coprecipitation of the glycine-HC1 eluates with IgG aggregates gave a small, but distinct peak corresponding to a tool wt of 28,000.
Isolation of the 28,000-dalton protein with IgG aggregates was not inhibited by earrageenin (500/zg/ml) or polyinosinic acid (500/tg/ml). Significant amounts of Fcy-receptor-like protein were solubilized only with a mixture of EDTA and ME (Fig. 7, dotted line) . With EDTA (not shown) or ME alone, no, or only very small amounts of, FcT-receptor-like protein was solubilized (Fig. 7, solid line) , showing that both the ,removal of divalent cations and dissociation of disulfide bridges are necessary for liberation of the FcT-receptor molecules from the membranes.
To obtain data on the FcT-receptor-like molecules under nonreducing conditions, we dialyzed EDTA-ME lysates against oxygenated PBS supplemented with protease inhibitors. Coprecipitates obtained from the dialysate with IgG aggregates displayed two new peaks in SDS-polyacrylamide gel electrophoresis performed under nonreducing conditions, viz.: a large peak with an apparent tool wt of 115,000 and a smaller one with an apparent tool wt of 18,000 (Fig. 8) . The 115,000-dahon component could be readily dissociated into a 28,000-dahon protein by adding ME.
The isoelectric-focusing pattern of total EDTA-ME membrane lysates is shown in Fig. 9 A. Twelve distinct peaks are discernible. After absorption of the lysate with IgG aggregates followed by precipitation with anti-IgG serum, one maior peak with an isoelectric point (pI) of 5.5 was missing (Fig. 9 B) . The missing peak, representing the Fc),-affined protein, with a pI of 5.5 could be recovered by isoelectric focusing of the coprecipitate (Fig. 9C ). same conditions as those for isolation of the Fc), receptor. As demonstrated in Fig. 10 , C 1 q bound to IgG aggregates showed a major peak of 58,500 daltons, four very small peaks of 41,000, 34,000, 28,000, and 20,000 daltons, and a large peak of <t0,000 daitons.
Electrophoretic Pattern of Clq Solubilized with EDTA-ME and Isolated with IgG Aggregates. Because some of the properties of the Fcy-binding protein resembled those of
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Detection of Clq and Fcy-Receptor Protein in EDTA-ME Membrane Lysates.
To determine whether the EDTA-ME lysates contain C lq or its subunits with the capacity to bind complexed IgG, we incubated Ehu and Ehu densely coated with incomplete human anti-D antibodies (EhuA) in EDTA-ME lysates. agent. We were not able to select an FcT region-specific protein, however, from the NP-40 membrane lysates of leukemic B cells. Six SDS-electrophoretically identical proteins were isolated with IgG aggregates and F(ab')2 aggregates. The mol wt of the six proteins ranged from 115,000 to 15,000. This finding indicates that NP-40 liberates proteins that can be bound to both F(ab')2 and IgG aggregates. F(ab')2-affined membrane proteins were recently described (34, 35) . It is not clear why similar proteins were isolated from NP-40 lysates with IgG and F(ab')z aggregates. A possible explanation is that the six isolated proteins are associated by NP-40 to a complex, or that they chiefly represent a membrane complex that includes proteins with an affinity to bind to aggregates of IgG and F(ab')2. This heterogeneous complex precipitates with IgG and F(ab')2 aggregates as a single entity and is reduced to its individual protein components when the precipitates are prepared for SDS electrophoresis. Because we obtained similar nonspecific results with DOC lysates, we concluded that detergents are not suitable for the solubilization and isolation of Fcyreceptor molecules. We therefore tried nondetergent solvents. These have the advantage that they do not lysate antibody-coated indicator cells (EA). Using the mixture of EDTA and ME described by Rask et al. (11) as a potent solvent of Fcy-receptor molecules, we could solubilize material from membranes of the leukemic B cells that strongly inhibited the binding of IgG-EoxA to Fcy-receptor-positive leukemic cells. The inhibitory activity was readily removed by exhaustive absorption of the EDTA-ME solubilisate with IgG-EoxA, but not with Eox. This eliminates the possibility that EA-rosette formation was suppressed either nonspecificaUy or by contaminating amounts of cytophilic IgG. The findings justify the conclusion that the inhibitory activity of the lysate actually represents solubilized Fcy-binding protein.
Because of the reported susceptibility of solubilized Fcy-receptor-like material to proteolysis (17), we started the isolation procedure with EDTA-ME membrane lysates immediately after iodination, without removing the unbound iodine by dialysis. The free iodine was removed by exhaustive washing in PBS after absorption or coprecipitation of the lysates with the substrates. Various methods and substrates were used for isolation of proteins with the capacity to bind to the Fc portion of IgG, viz.: coprecipitation with aggregated IgG and antigen-antibody complexes (PAP-IgG), absorption with IgG-coated E membrane sheets, absorption with aggregated IgG and CPM xl0 -2 14" 115,000
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Flo. 8. SDS polyaerylamide gel profiles of EDTA-ME-solubilized, iodinated membrane proteins eopreeipitated with aggregated IgG after exhaustive dialysis against oxygenated PBS supplemented with protease inhibitors.
PAP-IgG complexes attached to Sepharose 4B, and affinity chromatography on aggregated IgG-Sepharose 4B columns. Fundamentally identical results were obtained with all methods and substrates used: SDS electrophoresis revealed one peak corresponding to a moi wt of 28,000. The highest peaks were obtained with PAP-IgG complexes. Affinity chromatography with glycine-HCl elution of the bound proteins yielded less significant peaks. When uncoated E membrane sheets, IgG-F(ab')~ aggregates, or PAP-F(ab')2 complexes were used for absorption, no peak could be found in SDS electrophoresis, showing the specific binding of the isolated protein to IgG and within the IgG molecule to the Fc region. Neither with IgG aggregates nor with PAPIgG complexes were significant amounts of Fcy-affined protein detectable in the EDTA-ME extracts of membranes from an Fcy-receptor-negative T-cell leukemia or Ehu. Isoelectric focusing of the isolated Fcy-affined protein showed a single peak with a pI of 5.5, indicating that the isolated 28,000-dalton protein was composed of homogeneous polypeptide chains. Because the relative mobility of the isolated protein in SDS electrophoresis was not altered after reduction and alkylation, we concluded that the protein consisted of one polypeptide chain. Another finding in favor of this conclusion was that only one NH2-terminal amino acid (glycine) was detected on isolated Fcy-receptor protein. Even concentrated EDTA-ME lysates did not agglutinate Eo,A, suggesting that the Fcy-receptor protein we solubilized has only one binding site. The failure to isolate any peaks discernible in SDS-polyacrylamide gel electrophoresis or isoelectric focusing with F(ab')2 aggregates demonstrates that proteins with affinity to F(ab')2 are not liberated by EDTA-ME, whereas they are liberated by NP-40.
It is interesting that significant amounts of Fcy-receptor protein were solubilized only with a mixture of EDTA and ME. With EDTA or ME alone, no, or only small amounts of, Fcy-receptor protein was solubilized. That suggests that divalent cations and disulfide bridges are involved in the linkage of the Fcy-receptor protein to the cell membrane. Although the specificity of the isolated protein for the Fc region of aggregated IgG was clearly demonstrated, we cannot conclude that the protein was a complete Fcy-receptor molecule. The isolated Fcy-receptor-binding protein might be bound to integral membrane proteins, which have yet to be identified, via disulfide bonds and divalent cations. Thus, we may merely conclude that the isolated protein represented at least the part of the Fcy receptor of leukemic B cells that is responsible for binding to the Fc portion of IgG.
There have been only two other reported attempts to solubilize Fcy-receptor molecules with nondetergent agents. In the first study (11) , a mixture of EDTA and ME was used. The authors isolated IgG-binding molecules from murine spleen cells by absorption and desorption on a Sephadex column to which IgG aggregates were attached. The eluted protein differed, however, in molecular weight (68,000, 18,000, and 15,000) from the protein we isolated. In the second study (14) , cell membranes were solubilized with lithium diiodosalicylate. The authors isolated three proteins with mol wt of 65,000, 45,000, and 28,000 from murine leukemia cells with monomeric IgG, and an additional protein with a mol wt of 125,000 with antigen-complexed IgG. Only the 125,000-dahon protein was dissociated into two smaller subunits with mol wt of 74,000 and 60,000.
)H ' 11 10 '9 "8 .7 "6 "5 ./. The literature contains reports on four studies (12, (16) (17) (18) using detergents to solubilize IgG-binding proteins. The proteins isolated in those experiments differed greatly in mol wt (24,000-125,000) and in their susceptibility to reduction. It is notable, however, that in two of those studies the Fcy-binding proteins revealed apparent mol wt of 110,000 and 120,000, respectively, under nonreducing conditions. Two research groups (13, 15) looked for Fcy-binding material either spontaneously released from cells or released by shedding with IgG aggregates and anti-IgG antibodies. One group (13) reported on the isolation of a 45,000-dalton protein from a murine leukemia cell line (L1210) and the other (15) on a 100,000-dalton protein from human lymphoid cell lines.
On the whole, the data in the literature on Fcy-binding proteins are very confusing. Because the mentioned studies differed chiefly in cell sources and solvents, it is not clear which of these parameters is responsible for the differences in the results. Furthermore, there is also the possibility of nonspecific interaction during the isolation procedure. For these reasons, we performed a large number of control experiments in the present study. As long as it is not possible to measure the biological effect induced by binding of ligands to Fcy receptors, the only way to test the specific binding of IgG to Fcy receptors is to perform control experiments with F(ab')2 fragments of IgG. Such control experiments do not, however, rule out the possibility that aggregated or complexed IgG is bound to cell-membrane proteins that do not act as Fcy receptors, but rather capture the IgG via nonspecific hydrophobic interaction. On the other hand, this problem also arises with Fcy-receptor assays of intact lymphoid cells.
As far as we know, none of the published studies contains a report on the isolation of a single polypeptide chain with a mol wt of 28,000 under reducing conditions. To enable a comparison of the isolated Fcy-binding protein not only with the reduced Fcy-receptor-like molecules described by other authors but also with nonreduced molecules, and to obtain data on the aggregation properties of the IgG-binding protein that we isolated, we dialyzed EDTA-ME lysates against oxygenated PBS. With this procedure, the FcT-binding protein changed its mol wt to 115,000, probably by forming tetramers. The 115,000-dalton protein was reminiscent of the 125,000-dalton peak of Cooper et al. (14) , the 120,000-dalton peak of Bourgeois et al. (17) , the 110,000-dalton peak of Frade and Kourilsky (16) , and the 100,000-dalton peak of Molenaar et al. (15) . The Fcy-binding proteins described by those authors might correspond to the tetrameric FcT,-affined proteins that we isolated. This assumption would explain why the 100,000-dalton protein described by Molenaar et al. (15) was able to agglutinate EA and our 28,000-dalton peak was not. In its tetrameric form, the IgG-binding protein should be muhivalent and thus capable of agglutinating EA. We have started investigations of these possibilities. It has been reported that isolated C lq binds firmly to human lymphocytes (36) and thus might be responsible for the binding of IgG aggregates. To study the possibility of the Fcy-receptor molecule being identical with Clq, we investigated one of the three B-type lymphoid leukemias that we used as sources of IgG-binding material, for the presence of C 1 q on the cell membrane. All of the cells from this ease (B-type PLL) showed strong staining for Clq in double-layer immunofluorescence. From the following findings, we concluded that Clq and the FcT-binding protein isolated in this study are different structures: (a) The cells from all three cases of B-type leukemia formed rosettes only with IgG-EA complexes (40-95%) and not with IgM-EA (0-3%). If the Fc~,-receptor activity of the leukemic cells were mediated by C lq, both IgG-EA complexes and IgM-EA would be bound, because Clq reacts with the Fc fragments of both IgG and IgM (37) . (b) EA-rosette formation by the Clq-bearing leukemic cells was not depressed by anti-Clq serum, but was remarkably inhibited by antiFcy-receptor sera. (c) Carrageenin or polyinosinic acid did not inhibit the binding of the 28,000-dalton protein to IgG aggregates; these substances are known to inhibit the binding of Clq to complexed IgG (37, 38) . (d) In SDS-polyacrylamide gel electrophoresis, C 1 fragments isolated with IgG aggregates under the conditions used for the isolation of the Fcy-binding membrane protein showed one large peak of FcT-BINDING PROTEIN FROM LEUKEMIC B CELLS 58,500 daltons and no predominant peak in the 28,000-dalton region. (e) EA preincubated in EDTA-ME lysates displayed brilliant fluorescence with antisera directed against the Fcy-binding protein, but not with anti-Clq sera.
The data presented here show that the Fc~,-binding protein that we isolated from leukemic B cells consists of a single polypeptide chain and has an apparent mol wt of 28,000 and a pI of 5.5. This structure has only one binding site, and its linkage to the cell membrane is apparently mediated by divalent cations and disulfide bridges. These features suggest that the isolated Fcy-binding protein is not an integral membrane protein, as defined by Singer et al. (39) , but rather, an associated membrane protein; it represents either a complete receptor molecule or at least the fragment of Fcy receptors that is responsible for binding to the Fc portion of IgG. The 28,000-dalton Fc~,-binding protein tends to aggregate, probably to tetramers, in the absence of ME and might be expressed on the cell membrane in the form of tetramers. Summary A selectively Fcy-binding protein was isolated from purified and radioiodinated cell membranes from two cases of B-type chronic lymphocytic leukemia and one case of B-type prolymphoeytic leukemia by binding to IgG aggregates, horseradish peroxidase-anti-peroxidase IgG complexes, and sheep erythrocyte membrane sheets densely coated with IgG. This protein could not be isolated from the cell membranes of an Fcl,-receptor-negative chronic lymphocytic leukemia of the T type or from membranes of human erythrocytes. The Fcy-binding protein was efficiently solubilized by a mixture of Na-EDTA and 2-mercaptoethanol, but not with one of these agents alone, indicating that both divalent cations and disulfide bridges are involved in the linkage of the Fcy-binding protein to the cell membrane. In sodium dodecyl sulfate-polyacrylamide gel electrophoresis, the Fcy-binding protein revealed an apparent tool wt of 28,000, and in isoelectric focusing it showed an isoelectric point of 5.5. The electrophoretic mobility of the 28,000-dalton protein did not change after reduction and alkylation. It was determined that the NH2-terminal amino acid of the protein was glycine. The isolated protein was unable to agglutinate antibody-coated erythrocytes. These findings suggest that the 28,000-dalton IgG-affined protein was composed of one polypeptide chain with one Fc~,-region-specific binding site. When exposed to O2-enriched buffer lacking reducing agents, the 28,000-dalton protein aggregated to a 115,000-dalton molecule. The isolated Fc~,-binding protein proved to be different from Clq or its subunits.
